The chapter discusses the testing of FDA approved drugs, such as meclazine and Astaxanthine, for their effects on lifespan and aging in mice. It also mentions the lack of belief in the role of senescent cells in aging and the need for nuance and specificity when discussing synolytics and senescent cells. The chapter concludes with a mention of popular anti-senescent drugs, Fisetin and quercetin-dasatinib.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode